Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
88.77
-0.59 (-0.66%)
Dec 23, 2025, 4:00 PM EST - Market closed
Globus Medical Market Cap
Globus Medical has a market cap or net worth of $11.88 billion as of December 24, 2025. Its market cap has increased by 4.72% in one year.
Market Cap
11.88B
Enterprise Value
11.59B
1-Year Change
4.72%
Ranking
Category
Stock Price
$88.77
Market Cap Chart
Since August 3, 2012, Globus Medical's market cap has increased from $1.22B to $11.88B, an increase of 873.68%. That is a compound annual growth rate of 18.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 11.88B | 5.49% |
| Dec 31, 2024 | 11.26B | 53.38% |
| Dec 29, 2023 | 7.34B | -0.98% |
| Dec 30, 2022 | 7.42B | 1.22% |
| Dec 31, 2021 | 7.33B | 13.84% |
| Dec 31, 2020 | 6.44B | 9.95% |
| Dec 31, 2019 | 5.85B | 37.32% |
| Dec 31, 2018 | 4.26B | 7.60% |
| Dec 29, 2017 | 3.96B | 66.61% |
| Dec 30, 2016 | 2.38B | -10.27% |
| Dec 31, 2015 | 2.65B | 17.98% |
| Dec 31, 2014 | 2.25B | 19.34% |
| Dec 31, 2013 | 1.88B | 96.83% |
| Dec 31, 2012 | 956.00M | -21.65% |
| Aug 3, 2012 | 1.22B | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |